Position in KRRO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$532,339
+$182,393 QoQ
Shares Held
40,390
+30.7% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 106 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRRO Over Time
Shares Held
Position Value (USD)
Derivatives in KRRO
reported options exposure · as of Jun 30, 2026CallValue
$935,780
CallShares
71,000
PutValue
$163,432
PutShares
12,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. KRRO ranks #265 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in KRRO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,432 | 12,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $532,339 | 40,390 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $935,780 | 71,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $786,740 | 69,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,909,684 | 168,700 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $349,946 | 30,914 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $467,215 | 58,329 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $117,747 | 14,700 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $2,234,790 | 279,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $7,371,611 | 153,928 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,379,568 | 350,646 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,409,082 | 253,250 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,075,735 | 369,733 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,684,961 | 529,173 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,923,089 | 529,173 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $47,626,200 | 529,180 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,363,261 | 529,173 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,629 | 34 | Call | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||